+ All Categories
Home > Documents > 21 Apr to Jun 2016 - ADMA › downloads › Ayurbiz -Apr to June 2016.pdfBenchmarks for practice in...

21 Apr to Jun 2016 - ADMA › downloads › Ayurbiz -Apr to June 2016.pdfBenchmarks for practice in...

Date post: 26-Jan-2021
Category:
Upload: others
View: 0 times
Download: 0 times
Share this document with a friend
8
Apr to Jun 2016 During the Managing Committee Meeting held on 5th January 2016 it was proposed for Organizing Workshop on following places 1) Kolkata 5) Lucknow 2) Bangalore 6) Rajasthan 3) Kerala 7) Chennai 4) Pune 8) M. P. I am happy to inform all the members that on 1st March 2016 Workshop on recent development & Challenges was organized by Ayurvedic Drug Manufacturers' Association (ADMA) at Kolkata, in Association with Ayurvedic Drug Manufacturers Association of India (ADMAI) where in 74 delegates attended this Workshop in addition to Government officials. We are indeed thankful to Dr. Pawan Sharma, Mr. Shyam Sundar Sharma, Dr. G. P. Sarkar and the entire Team of ADMAI for their co-operation and painstaking efforts in making the Workshop a Grand success! Our special thank to Mr. A. R. Sarkar who coordinated between ADMA and ADMAI. We are extremely thankful to our esteemed Speakers Dr. Nagesh Sandu, Mr. Ranjit Puranik, Dr. C. K. Katiyar, Dr. Amit Agarwal and Mr. Manoj Bakalkar all of whom delivered excellent, learned presentation which besides imparting knowledge evoked good interaction and dialogue with the participating audience. Last but not the least my special thanks to Dr. Nagesh, Chairman Technical Committee who has taken lead to organize Kolkata Workshop. All Members are aware about my earlier appeal to send their voluntary contribution towards Biodiversity matter to ADMA secretariat. It has been observed that some of our members are not yet sent in their contribution. I once again appeal the members to contribute for the common and better cause. I warmly welcome M/s. Organic Industries Pvt. Ltd., Mumbai, M/s. Srushti Industries, Amravati, and M/s. Cure Medicine, Pune who have enrolled as annual members of ADMA and look forward to their active participation in the Associations activities. 21
Transcript
  • Apr to Jun 2016

    During the Managing Committee Meeting held on 5th

    January 2016 it was proposed for Organizing Workshop

    on following places

    1) Kolkata 5) Lucknow

    2) Bangalore 6) Rajasthan

    3) Kerala 7) Chennai

    4) Pune 8) M. P.

    I am happy to inform all the members that on 1st March 2016 Workshop on

    recent development & Challenges was organized by Ayurvedic Drug

    Manufacturers' Association (ADMA) at Kolkata, in Association with

    Ayurvedic Drug Manufacturers Association of India (ADMAI) where in 74

    delegates attended this Workshop in addition to Government officials.

    We are indeed thankful to Dr. Pawan Sharma, Mr. Shyam Sundar Sharma,

    Dr. G. P. Sarkar and the entire Team of ADMAI for their co-operation and

    painstaking efforts in making the Workshop a Grand success!

    Our special thank to Mr. A. R. Sarkar who coordinated between ADMA and

    ADMAI.

    We are extremely thankful to our esteemed Speakers Dr. Nagesh Sandu,

    Mr. Ranjit Puranik, Dr. C. K. Katiyar, Dr. Amit Agarwal and Mr. Manoj

    Bakalkar all of whom delivered excellent, learned presentation which

    besides imparting knowledge evoked good interaction and dialogue with

    the participating audience.

    Last but not the least my special thanks to Dr. Nagesh, Chairman

    Technical Committee who has taken lead to organize Kolkata Workshop.

    All Members are aware about my earlier appeal to send their voluntary

    contribution towards Biodiversity matter to ADMA secretariat. It has been

    observed that some of our members are not yet sent in their contribution. I

    once again appeal the members to contribute for the common and better

    cause.

    I warmly welcome M/s. Organic Industries Pvt. Ltd., Mumbai, M/s. Srushti

    Industries, Amravati, and M/s. Cure Medicine, Pune who have enrolled as

    annual members of ADMA and look forward to their active participation in

    the Associations activities.

    21

  • Apr to Jun 2016

    1) We had requested Smt. Shomita

    Biswas, Chief Executive Officer, National

    Medicinal Plant Board (NMPB), Ministry of

    AYUSH, Government of India, New Delhi,

    seeking feedback and views/ suggestions placed before

    Hon'ble Minister of Health and Family Welfare, Bangladesh

    during the Indian delegation from Ministry of AYUSH,

    Government of India on 4th November 2015, vide our letter no.

    0116/ADMA/NMPB/470 dated 15th January 2016. However,

    we have not received any response on the same even after our

    repeated follow up.

    2) On 7th January 2016, during International

    Conference on Advances in Asian Medicine (ICAAM)

    organized by Indian Association for Study of Traditional Asian

    Medicine (IASTAM), around table conference on Industry

    issues such as Biodiversity, GST and Government scheme for

    Industry was discussed with the officials of Ministry of AYUSH.

    3) On 15th January 2016 our Association had sent

    reminder to Secretary, Ministry of AYUSH to give an

    appointment to discuss about Industry related issues.

    However, in spite of follow up we have not received any

    response on the same.

    4) On 23rd January 2016, during Arogya Sanjeevanee

    Conference organized by Keshv Srushti, Bhainder, Minister of

    AYUSH Shri Shripad Rao Yasso Naik, was invited by the

    organizer for the inaugural function and ADMA had opportunity

    to make the presentation on some of the issues faced by the

    Industry. Joint Secretary, Mr. Shashank Sandu explained in

    detail the impact of each of the following issues :

    1. CoPP

    2. Getting Observer status for Indian Government &

    Industry

    3. Phytoparmaceuticals & Nutraceuticals

    4. Schemes for AYUSH Industry- Not declared under

    12th Five Year Plan.

    5. Biodiversity- Industry viewpoint

    6. Procurement preferences given to PSU under NRHM

    7. Levy of Central excise duty on Ayurvedic products

    8. Regulations affect the smooth flow of trade in

    medicinal plants due to provisions of the Indian

    Forest Act 1927 and Wild Protection Act 1972

    9. Weight & Measures ACT

    10. Non reimbursement claims against the participation

    in Arogya & Internationals Events

    5) On 4th February 2016, Ministry of AYUSH had invited

    ADMA representatives for the meeting to discuss issues of

    ADMA/ AYUSH Drug Manufacturers concerns relating to

    Biological diversity, under the Chairpersonship of Chief

    Executive, NMPB. Minutes of the meeting received on 18th

    March 2016 is reproduced in page no.

    6) We had Organized One day Workshop at Golden

    Parkk Hotel, Kolkata on 1st March 2016 for appraising and

    updating the members and recent development and

    challenges facing ASU Industry. The following Speakers

    made presentations on the respective topics

    a) Dr. G. P. Sarkar, President, ADMAI and Dr. Pawan

    Kumar Sharma, Vice President, ADMAI, updated on a status of

    Ayurvedic Drug Manufacturers in West Bangal.

    b) Dr. Nagesh Sandu, Chairman Technical Committee,

    ADMA, Director, M/s. Sandu Brothers Pvt. Ltd., and Mr.

    Ranjit Puranik, Vice President (West), ADMA, Executive

    Director, M/s. Dhootapapeshwar Ltd., Mumbai, updated on

    current matters being represented AYUSH.

    c) Dr. Amit Agarwal, Vice President (South), ADMA,

    Director, M/s. Natural Remedies Pvt. Ltd., Bangalore, updated

    on Biodiversity Act: Basics & its Implications to Ayurvedic

    Industry.

    d) Dr. C. K. Katiyar, Vice President (North), ADMA, CEO

    Healthcare (Technical), M/s. Emami Limited, Kolkata, updated

    on Shelf Life: Recent Notification.

    e) Mr. Bakalkar, Manager, Packaging Development,

    M/s. Charak Pharma :Limited, Mumbai, updated on Bar

    Coding.

    7) ADMA had sent its comments on Pharmacy Bill 2016,

    to Shri Jitendra Sharma, Joint Secretary, Ministry of AYUSH

    vide letter no. 0316/ADMA/503 dated 22nd March 2016.

    8) We have also sent our submission to Hon'ble Minister

    for AYUSH on 29th March 2016 with the request for

    intervention to Bangladesh embassy to resolve the issues

    related to manufacturing of Ayurvedic products in Bangladesh.

  • Will the Minister of AYURVEDA, YOGA & NATUROPATHY, UNANI, SIDDHA AND HOMOEOPATHY (AYUSH) be pleased to state:

    (a) whether the Government is considering to establish a National Board for promotion of Yoga and Naturopathy;

    (b) if so, the details thereof;

    (c) whether the Government has proposed to sign an agreement with WHO for collaborative activities in the area of traditional medicine and to organise conference to popularize the Indian system of medicines; and

    (d) if so, the details thereof?

    THE MINISTER OF STATE (IC) OF THE MINISTRY OF AYURVEDA, YOGA & NATUROPATHY, UNANI, SIDDHA AND HOMOEOPATHY (SHRI SHRIPAD YESSO NAIK)

    (a) & (b): Yes. A Task Force constituted by the Ministry of AYUSH in its recommendations has suggested to constitute a National Board for Promotion & Development of Yoga and Naturopathy under the Chairmanship of Secretary (AYUSH) with the following aims & objectives :-

    1)To enhance the quality of Yoga & Naturopathy education, training, therapy and research;

    2)To develop human resource in Yoga & Naturopathy ;To develop standards for Yoga & Naturopathy training and practices for voluntary adoption; iv.To promote accreditation frame work relating to Yoga and Naturopathy

    ANSWER

    Apr to Jun 2016 3

    National Board for Yoga and Naturopathy

    UNSTARRED QUESTION NO: 2530ANSWERED ON:11.03.2016

    DHARMENDRA YADAVfor voluntary implementation by institution including drafting of curriculum and syllabus for various degrees, diploma and programmes;

    v. To promote & propagate Yoga & Naturopathy at International level;

    vi. To institute national awards for outstanding for outstanding contribution to Yoga & Naturopathy; vii.To develop methods of competence, and evaluation of Yoga & Naturopathy practitioners; viii.Any other item relating to development & promotion of Yoga & Naturopathy.

    (c) & (d): Yes. The Cabinet in its meeting held on 17.02.2016 has approved the proposal of the Ministry of AYUSH to sign as agreement with WHO for collaborative activities in the area of traditional Medicine. The Ministry has also agreed in principle to the proposal of Ambassador and Permanent representative of India to the United Nations in Geneva to organize on Official Side. Event Traditional systems of Medicine during the 69th world Health Assembly during May, 2016. As a first step in the long term collaboration. India would assign to WHO activities for development of the following WHO technical documents/publications which will help in better international acceptability of Indian Systems of Medicine:-

    i. Benchmarks for training in Yoga;ii. Benchmarks for practice in Ayurveda;iii. Benchmarks for practice in Unani Medicine;iv. Benchmarks for practice in Panchakarma;

    PARLIAMENT NEWSIn Lok Sabha

  • Apr to Jun 2016

    PANKAJ CHOWDHARY

    Will the Minister of AYURVEDA, YOGA AND N AT U R O PAT H Y, U N A N I , S I D D H A A N D HOMOEOPATHY (AYUSH) be pleased to state:

    (a)whether the Government has formulated any policy for upgradation and renovation of AYUSHhospitals, medical institutes and dispensaries, if so, the salient features thereof;

    (b) the funds allocated for the purpose during the last three years and the current year, State/UT- wise;

    (c) whether the Government proposes to associate the Indian Council of Medical Research for realising full potential and developing herbal medicines through institutional programmes; and

    (d) if so, the details thereof along with the funds allocated for the purpose?

    Will the Minister of AYURVEDA,YOGA & N AT U R O PAT H Y, U N A N I , S I D D H A A N D HOMEOPATHY (AYUSH) be pleased to state:-

    THE MINISTER OF STATE (IC) OF THE MINISTRY OF AYURVEDA, YOGA & NATUROPATHY, UNANI, SIDDHA AND HOMOEOPATHY(AYUSH)(SHRI SHRIPAD YESSO NAIK)

    (a) to (d): A statement is laid on the Table of the HouseSTATEMENT REFERRED TO IN REPLY TO LOK SABHA STARRED QUESTION NO 202 FOR 11TH MARCH, 2016

    (a)Government of India evolved the National Policy on Indian Systems of Medicine & Homoeopathy-2002 for the development of various disciplines of Indian Systems of Medicine which inter-alia envisage the following:

    (i)To promote good health and expand the outreach of health care to our people, particularly those not provided health cover, through preventive, promotive, mitigating and curative intervention through Indian Systems of Medicine & Homoeopathy (ISM&H).

    (ii)To improve the quality of teachers and clinicians

    ANSWER

    by revising curricula to contemporary relevance and researches by creating model institutions and Centres of Excellence and extending assistance for creating infrastructural facilities.

    (iii)To ensure affordable ISM&H services and drugs which are safe and efficacious. Further, the Central Government launched National AYUSH Mission (NAM) on 29.09.2014 which envisages better access to AYUSH services, strengthening of AYUSH educational institutions, facilitate the enforcement of quality control of Ayurveda, Siddha and Unani & Homoeopathy (ASU&H) drugs and sustainable availability of ASU & H raw-materials in the States /Uts during 12th Plan. The NAM inter-alia makes provision for upgradation and renovation of AYUSH hospitals, medical institutes and dispensaries. The details are furnished at ANNEXURE-I.

    (b) The funds allocated for the upgradation and renovation of AYUSH hospitals, AYUSH medical institutes and AYUSH dispensaries during the last three years and the current year, State/UT-wise is furnished at ANNEXURE-II.

    (c) and (d). Central Council for Research in Ayurvedic Sciences (CCRAS) and Central Council for Research in Unani Medicine (CCRUM), both autonomous bodies under the Ministry of AYUSH have signed Memorandum of Understanding (MOU) with Indian Council of Medical Research (ICMR) for undertaking collaborative research projects under their respective schemes and programmes. CCRAS have taken up collaborative projects under Reproductive and Child Health (RCH) Programme, Golden Triangle Partnership (GTP) Scheme, Extra Mural Research (EMR) Scheme of Ministry of AYUSH. CCRUM is collaborating in the field of Tuberculosis with National Institute for Research in Tuberculosis (NIRT), Chennai, which is one of the premier institutes of ICMR.

    To converge the research approach of AYUSH systems with the modern system of medicine, the Ministry of AYUSH and Indian Council of Medical Research (ICMR) have together decided to have molecular based studies on specific leads from AYUSH.

    No separate funds are allocated for this purpose.

    GOVERNMENT OF INDIA

    MINISTRY OF AYURVEDA,YOGA & NATUROPATHY,UNANI,SIDDHA AND HOMEOPATHY (AYUSH)

    LOK SABHASTARRED QUESTION NO: 202

    ANSWERED ON:11.03.2016Upgradation/Renovation of AYUSH Hospitals

  • Apr to Jun 2016

    RAMESH POKHRIYAL NISHANK

    Will the Minister of AYURVEDA, YOGA AND

    N AT U R O PAT H Y, U N A N I , S I D D H A A N D

    HOMOEOPATHY (AYUSH) be pleased to state:

    (a) the percentage of population dependent on

    AYUSH system of medicine in the country;

    (b) whether the Government proposes to spread as

    well as preserve the knowledge of Ayurvedic

    medicines available in manuscripts, ancient books

    and other sources; and

    (c) if so, the steps taken by the Government in this

    regard including digitization of rare books and

    patenting of traditional medicines?Will the Minister of AYURVEDA,YOGA &

    N AT U R O PAT H Y, U N A N I , S I D D H A A N D

    HOMEOPATHY (AYUSH)be pleased to state:-

    THE MINISTER OF STATE (IC) OF THE MINISTRY

    OF AYURVEDA, YOGA & NATUROPATHY, UNANI,

    SIDDHA AND HOMOEOPATHY(AYUSH)(SHRI SHRIPAD YESSO NAIK)

    (a) to (c): A statement is laid on the Table of the HouseSTATEMENT REFERRED TO IN REPLY TO LOK

    SABHA STARRED QUESTION NO 213 FOR 11TH

    MARCH, 2016

    (a)National Sample Survey Office (NSSO) has

    undertaken a survey on social consumption in India

    on Health in its 71st round conducted during January

    – June 2014. As per key indicators released recently

    by NSSO for the 71st round, it is estimated that about

    6% of the people have received treatment from

    Indian Systems of Medicine (including Ayurveda,

    Unani and Siddha),

    Homoeopathy and Yoga & Naturopathy.

    ANSWER

    (b) Central Council for Research in Ayurvedic

    Sciences (CCRAS) is engaged in the studies related

    to revival & retrieval and digitization of Ancient

    Ayurvedic Manuscripts & Rare Books and they are

    being published from time to time, so far 30 books

    retrieved from manuscripts have been published and

    are now available in the public domain. (Annexure-I)

    Besides this, the Council has surveyed and digitized

    more than 5000 Ayurvedic Manuscripts/Rare Books

    from Odisha, West Bengal, Bihar, Andhra Pradesh,

    Tamilnadu, Karnataka, Kerala, Madhya Pradesh,

    Maharashtra, Assam and Jammu & Kashmir (Leh)

    etc.

    (c) Ministry of AYUSH had given financial assistance

    to 31 institutes to preserve rare and

    precious AYUSH books for translation & publication

    under Central Sector Scheme, Acquisition,

    Cataloguing, Digitization and Publication of Text

    Books & Manuscripts (ACDP) implemented during

    11th Plan. The Centre for Traditional Medicine and

    Research, Chennai has collected 268 rare siddha

    palm manuscripts and digitized. Tamil Valarchi

    Kazhagam Chennai has published 8 volumes of

    Siddha medicines in Tamil (Annexure-II).

    As far as Unani system is concerned, Central Council

    for Research in Unani Medicine (CCRUM) is also

    engaged in digitization of classical Unani

    book/manuscripts. So far 50 books manuscripts

    have been digitized by the Council (Annexure-III).

    As far as patenting of traditional medicines is

    concerned, 'an invention which, in effect, is

    traditional knowledge or which is an aggregation or

    duplication of known properties of traditionally known

    component or components' are not inventions and

    not patentable.

    GOVERNMENT OF INDIA

    MINISTRY OF AYURVEDA,YOGA & NATUROPATHY,UNANI,SIDDHA AND HOMEOPATHY (AYUSH)

    LOK SABHASTARRED QUESTION NO: 213

    ANSWERED ON:11.03.2016Patenting of Ayurvedic Medicines

  • Apr to Jun 2016

    Fiscal deficit & Borrowing program:

    The government continues with fiscal prudence by

    retaining fiscal deficit at 3.9% in 2015-16.

    It aims to achieve 3.5% in 2016-17 and 3% in 2017-18.

    Net borrowing program reduced to Rs. 4.2 lakh crore for

    2016-17 which is 6.5% lower than the budget estimates for

    net market borrowing in 2015-16.

    Subsidies:

    Overall subsidy to reduce from 1.9% of GDP in 2015-

    16 to 1.7% in 2016-17 (Budget Estimates)

    Infrastructure Outlay:

    Huge outlay for infrastructure of Rs. 2.21 lakh crore

    (+22.5% on RE) out of which Rs. 55k crore is

    budgeted for roads. Additional Rs. 15k crore to be

    raised by NHAI through bonds.

    LIC of India will set up a dedicated fund to provide

    credit enhancement to infrastructure project.

    Agriculture & Rural focus:

    The budgetary allocation to the ministry of Agriculture and

    farmers welfare rose by 93.8% YoY to Rs. 44,485 crore

    with a target to double farm income in next 5 years. Total

    allocation for the rural sector is Rs. 87,700 cr:

    Key schemes like the Pradhan Mantri Fasal Bima Yojana,

    Pradhan Mantri Krishi Sinchai Yojana and interest

    subvention schemes for farmers were also announced.

    The allocation to the schemes like Pradhan Mantri Gram

    Sadak Yojana (PMGSY) and MGNREGA were increased

    to focus on rural employment.

    Union Budget 2016-17 - Impact Analysis

    Fiscally prudent, soc ially redistributive is how we will define the budget. The Budget for FY17 reflects Government's firm

    commitment to substa ntially boost investme nt in Agriculture,Social Sector, Infr astructure and Employ ment generation on the one

    hand and simultaneously st icking to the fiscal consolidation path. The budget has tried to balance out the pain in rural sector and at

    the same time maintained investments in infrastructure by substantially reducing subsidies and factoring in conservative buoyancy

    in tax collections.

    We have summarized the key take-away from the budget and how it could impact us.

    This will create a substantial room for lower interest rates

    and will also leave more resources for the private sector to

    raise credit. This will also help to stabilize domestic macros

    in a volatile global environment and create room for RBI to

    resume further monetary easing.

    Long term bond yields rallied during the day of the budget

    announcement on the back of lower than expected net

    borrowing and expectation of a rate cut by the RBI.

    Government has aimed to help accelerate economic

    growth through higher spending on infrastructure

    and support for the agricultural sector, while also

    keeping deficit in check by targeting reduction in

    subsidies.idies.

    Increased investment in infrastructure will add more

    Value and Jobs to the GDP which will sep India on a

    sustainable growth path.

    The fund from LIC will help in raising the credit rating

    of bonds floated by infrastructure companies and

    facilitate investment from long term investors.

    Boosting farm income & Rural demand can lead to

    the agricultural sector becoming a key positive

    contributor to growth in 2016-17. This will help to

    boost the overall consumption demand in the

    economy which otherwise has been reeling under

    pressure due to 2 consecutive weak monsoons.

    This will direct impact on promoters and HNI' investors and

    may discourage direct stock investing. However, high

    dividend earning companies will continue to be not taxable

    as this levy is not applicable to corporate investors.

    Tax on Dividends:

    Individual, HUF and firms to pay 10% tax on dividend

    received from companies, if total dividend received during

    the year exceeds INR 10 lakhs. No deduction, expense or

    setoff available for such dividend income.

    Dividend received from MF investment continues to be

    outside this tax levy.

    Key Featu esr Impact

    Fiscal Policies

    1.

    2.

    3.

    4.

    1.

    Tax Policies

  • Apr to Jun 2016

    Unlisted Shares :

    Period for getting benefit of long term capital gain regime in

    case of unlisted companies proposed to be reduced from

    three to two years.

    Disallowance of expenditure incurred to earn exempt

    Income:

    Formula governing quantification of disallowance to be

    amended to limit the disallowance to 1% of the average

    monthly value of investment yielding exempt income, but

    not exceeding the actual expenditure claim.

    Presently, the limit of the disallowance was 0.5% of the

    average value of the investment yielding exempt income,

    on the first day and the last day of the previous year.

    REITS/INVIT's:

    Distribution made out of income of SPV to REITs and

    INVITs having specified shareholding will not be subjected

    to Dividend Distribution Tax, in respect of dividend

    distributed after the specified date

    Gold Monetisation Scheme Taxation:

    Deposit Certificates issued under Gold Monetisation

    Scheme, 2015 notified by the Central Government,

    excluded from the definition of capital asset and thereby to

    exempt if from capital gains tax. It is also proposed to

    provide that the interest on Deposit Certificates issued

    under the Schemes, shall be exempt from income-tax.

    New amnesty scheme for black money disclosure:

    Domestic taxpayers can declare undisclosed income or

    such income represented in the from of any asset by

    paying total tax of 45% of the undisclosed income & get

    immunity from prosecution under the Income Declaration

    Scheme, 2016 (IDS) from 1st June to 30th September

    2016

    Infrastructure & KK Cess:

    Infrastructure cess of 1% on small petrol, LPG, CNG cars,

    2.5% on diesel cares of certain capacity and 4% on other

    higher engine capacity vehicles and SUVs. No credit of

    this cess will be available nor credit of any other tax or

    duty can be utilized for paying this cess

    Krishi Kalyan Cess, @ 0.5% on all taxable Services, w.e.f.

    1 June 2016 making service tax rate at 15%

    Luxury tax on Cars:

    A 1% tax to be deducted on purchase of luxury cars for

    more than Rs. 10 lakhs and on cash transaction for more

    than Rs. 2 lakhs.

    STT on Options :

    STT on sale of Options when those are not exercised

    raised from 0.017% to 0.05%

    Surcharge :

    Increase in surcharge from 12% to 15% on individuals

    having income above Rs. 1 crore

    Benefits investments in venture capital or private equity

    funds that invest in unlisted securities of startups or growth

    stage (pre-IPO) investments.

    Will impact investors whose total income includes

    significant exempt income arising out of common

    expenses incurred for both non-exempt as well as exempt

    income.

    Removal of DDT is a positive step that may help in

    successful listing of REIT in future. The removal is likely

    to please institutional investors who view India as an

    untapped market for this asset class

    This will encourage investors to monetize their physical

    gold holdings.

    New amnesty scheme will be implemented for black

    money holders to come clean.

    Infrastructure cess would lead to increase in prices of

    passenger vehicles and may hurt volume growth for the

    industry.

    Krishi Kalyan Cess proceeds would be exclusively used

    for financing initiatives for improvement of agriculture and

    welfare of farmers.

    The focus of this initiative is to develop a tax trail to ensure

    lower black money transactions and increase tax receipts

    for the government.

    This will lead to high transaction cost for traders.

    This will lead to higher tax burden on HNI's.

    2.

    3.

    4.

    5.

    6.

    7.

    8.

    10.

    9.

  • Apr to Jun 2016

    Disclaimer: Any information contained in this material shall not be deemed to constitute an advice, an offer to sell/ purchase or as an

    invitation or solicitation to do for security of any entity and further ASK Wealth Advisors Private Limited (ASKWA) and its employees/

    directors shall not be liable for any loss, damage, liability whatsoever for any direct or indirect loss arising from the use of this

    information. Recipients of this information should exercise due care and caution (if necessary obtaining the advice of finance/ other

    professionals) prior to taking any decision on the basis of this information.

    ASK Wealth Advisors Private Limited has not independently verified all the information and opinions given in this material.

    Accordingly, no representative or warranty, express or implied, is made as to the accuracy, completeness or fairness of the

    information and opinions contained in this material.

    Other Key Policy Changes

    NPS/ EPF tax changes:

    Withdrawal up to 40% of corpus on retirement to be tax

    exempt for NPS. The annuity fund, if availed by the legal

    heir will also be tax exempt. Same norm to be applied to

    superannuation funds and recognized provident funds,

    including EPF in respect of corpus created out of

    contribution made on or from 1.4.2016.

    Contribution by employer towards employee PF of more

    than Rs. 150,000/- p.a. will be taxable. There was no limit

    earlier

    FDI up to 49% in insurance allowed under automatic route from previous limit of 26%

    FDI in ARCs was 100% but restricted to 49% per investor which has been removed. Complete pass through of

    income-tax to securitization trusts including trusts of ARCs. Securitization trusts required to deduct tax at source.

    FDI in Indian stock exchanges raised from 5% to 15%. At present, no single foreign entity can hold more than 5% in

    domestic exchanges.

    Advance tax payment schedule for non-corporate taxpayers aligned with that for corporate tax payers, effective 1 June 2016.

    Amendment to be brought in the RBI Act, 1934 to provide statutory basis for a Monetary Policy Framework and a

    Monetary Policy Committee

    Negative for salaried investors who will have to shell out

    a higher tax burden on long term retirement saving.

    11.

    1.

    2.

    3.

    4.

    5.

    Page 1Page 2Page 3Page 4Page 5Page 6Page 7Page 8


Recommended